It seems there was an error, as the content you provided is marked as "undefined." Please provide specific content for summarization.
AZN has been in the news recently: IonQ Inc. has attracted investor interest following partnerships and acquisitions, while Ionis Pharmaceuticals has received mixed ratings from analysts. Additionally, Novartis AG reported positive Phase 3B study results for Fabhalta in patients with paroxysmal nocturnal hemoglobinuria.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.